UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 0-22788
-------------------------
Axys Pharmaceuticals, Inc.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
180 Kimball Way, South San Francisco, California 94080
- --------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including
area code, of registrant's principal executive offices)
Common Stock, par value $.001 per share
- --------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
- --------------------------------------------------------------------------------
(Titles of all other classes of securities for which a duty to
file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule l2g-4(a)(1)(i) [X] Rule l2h-3(b)(l)(i) [X]
Rule l2g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ]
Rule l2g-4(a)(2)(i) [ ] Rule l2h-3(b)(2)(i) [ ]
Rule l2g-4(a)(2)(ii) [ ] Rule l2h-3(b)(2)(ii) [ ]
Rule l5d-6 [ ]
Approximate number of holders of record as of the certification or
notice date: One (1)
-------------------------------------------------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934,
Axys Pharmaceuticals, Inc. has caused this certification/notice to be signed on
its behalf by the undersigned duly authorized person.
Date: November 26, 2001 By: /s/ Thomas P. Livingston
------------------------------
NAME: Thomas P. Livingston
TITLE: Assistant Secretary